Rapivab 600mg/60mL IV Solution
Branded Rapivab peramivir injection 600mg in 60mL ready-to-use IV bags for influenza treatment. HTS 3004.90.92.05 due to peramivir content in measured prophylactic/therapeutic doses for retail sale.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If anti-infectives not specifically antivirals
IV solutions with other anti-infective agents classified under general categories.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Document complete cold chain from manufacture to entry per FDA guidance
• Provide drug master files for excipients in IV formulation
• Ensure overwrap removal instructions included for ready-to-use bags
Related Products under HTS 3004.90.92.05
Valganciclovir Hydrochloride 450mg Tablets
These are oral tablets containing 450mg of valganciclovir hydrochloride, an antiviral medication used to treat cytomegalovirus (CMV) infections in immunocompromised patients. Classified under HTS 3004.90.92.05 as an anti-infective antiviral medicament put up in measured doses for retail sale, consisting of valganciclovir salt in unmixed form.
Valcyte 450mg Film-Coated Tablets
Brand name Valcyte tablets with 450mg valganciclovir hydrochloride, film-coated for CMV retinitis and prevention in transplant patients. Falls under HTS 3004.90.92.05 due to specific valganciclopivir salt content in measured retail doses as an antiviral anti-infective.
Valganciclovir 50mg/mL Oral Suspension
Liquid oral suspension at 50mg/mL valganciclovir hydrochloride for pediatric or swallowing-impaired patients treating CMV disease. HTS 3004.90.92.05 applies as it's a measured dose antiviral containing valganciclovir salt for retail therapeutic use.
Peramivir 200mg Intravenous Injection
Single-dose 200mg vial of peramivir for IV infusion treating acute influenza in hospitalized patients. Classified in HTS 3004.90.92.05 as antiviral anti-infective in measured sterile doses containing peramivir for therapeutic use.
Valganciclovir Hydrochloride 900mg Extended-Release Tablets
High-dose 900mg extended-release tablets of valganciclovir HCl for once-daily CMV prophylaxis in transplant recipients. Falls under HTS 3004.90.92.05 as specified antiviral in measured retail doses despite modified release profile.
Pediatric Valganciclovir 250mg Tablets
Smaller 250mg valganciclovir tablets scored for pediatric dosing of CMV infections. HTS 3004.90.92.05 classification as measured antiviral doses containing valganciclovir salt for therapeutic retail sale.